Login
KAMAN Corp logo

KAMAN Corp

kaman.com

No Longer Reporting

The company has not filed an annual or quarterly report since its FY2023 10-K, filed Feb 22, 2024. Its latest SEC filing is a 15-12G from Apr 30, 2024.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Makes aircraft components and systems, aerostructures, and missile fuzes and helicopter services for aerospace and defense, industrial, and medical customers.

How Did They Make Money?

Customers pay for products and contract work; on certain long-term programs, Kaman earns its fee in proportion to progress toward completion.

revenue
SegmentShareRevenue
Military and Defense, other than fuzes
23%
FY2020: 23%
Missile and Bomb Fuzes
9.0%
FY2020: 32%
Commercial Aerospace
44%
FY2020: 28%
Medical
13%
FY2020: 8.9%
Other
11%
FY2020: 8.3%

Who Were Their Customers?

Customers include the U.S. and allied militaries and aerospace companies such as Boeing, Airbus, Sikorsky, and Lockheed Martin. Kaman also serves industrial and medical markets.

Did Revenues Turn Into Profits?

Yes. It kept 1 cent of every revenue dollar as net income in FY2023 and turned 6 cents into free cash flow.

Operating income, FY2023
6% of revenue
▲ Now profitable vs FY2022 (−$69.3M, −10%)
Net income, FY2023
1% of revenue
▲ Now profitable vs FY2022 (−$48.6M, −7%)
Free cash flow, FY2023
6% of revenue
▲ Now profitable vs FY2022 (−$2.7M, 0%)

How Were They Changing?

Since the FY2023 annual report
  • Apr 19, 2024 Arcline completed its acquisition of Kaman Shareholders received $46.00 per share in cash, and Kaman's common stock was delisted from the New York Stock Exchange.

Held flat. Revenue was $775.9M in FY2023, about the same as the $761.6M of FY2019.

Uncrewed aircraft The latest report describes development of the KARGO UAV logistics aircraft, while the older report described Kaman as manufacturing and supporting unmanned K-MAX helicopters.

Revenue over time
Military and Defense, other than fuzes Missile and Bomb Fuzes Commercial Aerospace Medical Other
$1B$500M$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support